Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis

Who May Qualify: - aged 18 years or older Fragility Nails Distal Subungual Onychomycosis Nail Psoriasis affecting ≤75% of the nail bed according to a photographic documentation and to a subjective evaluation by the Investigator. Who Should NOT Join This Trial: - Patients that have proximal subungual onychomycosis, if their distal subungual onychomycosis is extended into the proximal portion of the nail or if it affects \>75% of the nail. - Patients with conditions known to cause abnormal nail appearance, immunosuppression and signs of severe peripheral circulatory insufficiency - Patients who had used topical antifungal, anti-psoriasis nail treatment within one month or systemic antifungal treatment within three months. - Patients who have participated in another clinical nail study during the previous three months - Patients who have a known allergy to any of the study treatments. - Patients with unrelated nail disorders: onychomycosis, nail psoriasis, genetically induced onychodystrophy. - Patients with other nail disorders, active or severe psoriasis elsewhere, other autoimmune or inflammatory diseases. Always talk to your doctor about whether this trial is right for you.